Extracellular matrix and tenascin-C in pathogenesis of breast cancer

Lancet

Volumn 357, Issue 9273, 2001, Pages 1992-1994

  Jones, Peter Lloyd ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; COLLAGEN; ELASTIN; ESTROGEN; GLYCOPROTEIN; MATRIX METALLOPROTEINASE; PROTEINASE; PROTEOGLYCAN; STEROID RECEPTOR; STROMELYSIN; TENASCIN;

ANGIOGENESIS; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CARCINOMA IN SITU; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DNA MODIFICATION; EPITHELIUM CELL; EPITHELIUM HYPERPLASIA; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; INVASIVE CARCINOMA; MAMMARY GLAND; METASTASIS; NOTE; ONCOGENE C MYC; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0035938933     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)05133-3     Document Type: Note

References (15)

1. Tissue architecture and breast cancer: The role of extracellular matrix and steroid hormones
2. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
3. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy
4. Laminin inhibits estrogen action in human breast cancer cells
5. Targeting the EGF receptor in breast cancer treatment
6. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology
7. Disruption of matrix metalloproteinase 2 binding to integrin αvβ3 by an organic molecule inhibits angiogenesis and tumor growth in vivo
8. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
9. Tenascin - A marker for the malignant potential of preinvasive breast cancers
10. Expression of tenascin-C in intraductal carcinoma of human breast: Relationship to invasion
11. Tenascin-C expression in invasion border of early breast cancer: A predictor of local and distant recurrence
12. Tenascin-C in development and disease: Gene regulation and cell function
13. The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling
14. 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab′)2 - A preliminary report
15. Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas